Federated Hermes’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,274
Closed -$285K 2155
2026
Q1
$285K Buy
+37,274
New +$285K ﹤0.01% 1432
2025
Q3
Sell
-1,291
Closed -$12K 2210
2025
Q2
$12K Sell
1,291
-423
-25% -$3.69K ﹤0.01% 1796
2025
Q1
$16.7K Sell
1,714
-2,356
-58% -$29.2K ﹤0.01% 1753
2024
Q4
$49.3K Sell
4,070
-1,066
-21% -$13K ﹤0.01% 1668
2024
Q3
$56.3K Buy
+5,136
New +$52.2K ﹤0.01% 1636
2022
Q3
Sell
-3
Closed -$1K 2225
2022
Q2
$1K Sell
3
-127,318
-100% -$2.09M ﹤0.01% 2073
2022
Q1
$2.16M Buy
+127,321
New +$2.4M ﹤0.01% 1019
2021
Q1
Sell
-21,294
Closed -$812K 2331
2020
Q4
$812K Buy
21,294
+21,206
+24,098% +$884K ﹤0.01% 1394
2020
Q3
$2K Buy
88
+31
+54% +$706 ﹤0.01% 2105
2020
Q2
$1K Buy
+57
New +$1.01K ﹤0.01% 2169

Other funds holding REPL

Federated Hermes's REPL Position: Q2 2026 in Review

Federated Hermes sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 37,274 shares — an estimated $285K sold.

Federated Hermes first reported a position in REPL in Q2 2020 and held it in 10 quarters. The position peaked at $2.16M in Q1 2022. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Federated Hermes reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 37,274 Replimune Group shares in Q2 2026, an estimated $285K.
  • Federated Hermes first reported a position in Replimune Group in Q2 2020 and held it in 10 quarters.
  • Federated Hermes's Replimune Group position peaked at $2.16M in Q1 2022.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.